Delhi HC directs Sun Pharma to take permission before launching semaglutide
· livemint.com
Delhi High Court ordered Sun Pharma to seek judicial approval before launching semaglutide tablets, following a patent infringement suit by Novo Nordisk. The order requires Sun Pharma to return to court once it secures a manufacturing licence.
Yash Tiwari
Yash Tiwari is a Mumbai-based journalist who reports on corporate and regulatory developments, with a focus on court-driven policy shifts and the i...